Joel (he/him) graduated from the University of Connecticut with a B.A. in Psychological Science, Magna Cum Laude, in May 2021. While at the University of Connecticut, he was designated a Ronald E. McNair Scholar and his undergraduate research was overseen by the mentorship of Dr. Monnica Williams, who introduced Joel to issues surrounding racial trauma and inequities in inclusion of People of Color (POC) in psychedelic research, as well as the broad need for social justice among people from all identities. Prior to attending the University of Connecticut, he was formally trained as a certified Behavioral Health Specialist in the U.S. Army Reserves and underwent supervised clinical practicum at Ft. Sam Houston in San Antonio, TX.
After completing his undergraduate education, Joel held a Postgraduate Research Associate position at Yale’s School of Medicine, serving as the Lab Manager of the Race Equity and Addiction Lab in the Department of Psychiatry. Here, he explored various domains of phenomena associated with substance use disorders, such as self-change and craving, while implementing various community-based qualitative and integrative data analytic methodologies. He was simultaneously also a Clinical Research Assistant for the MAPS-sponsored, FDA multi-site expanded access study of MDMA for treatment resistant PTSD at the Behavioral Wellness Clinic, where he coordinated clinician training and ensured compliance with FDA and DEA requirements as outlined in the MAPS clinical trial protocol.
Throughout his education and previous professional endeavors; Joel also volunteered time, passion and energy as the Director of Finance for the Intercollegiate Psychedelics Network, where he established this international psychedelic organization as an incorporated non-profit, implemented programs to facilitate community connectedness and professional development among students, and developed a large network among the broad expanses of the psychedelic ecosystem. Joel is currently pursuing a Masters in Clinical Psychology at Teachers College, Columbia University, and he plans to pursue a Ph.D in Clinical Psychology after. He enjoys writing poetry, listening to music, and studying Buddhist philosophy in his free time.
Jeffrey Guss, MD
Psychoanalytic Program Director and Trainer
Dr. Jeffrey Guss is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy, addictions and psychedelic therapy. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress, and is currently is a study therapist on studies of Psilocybin-Assisted treatment of Major Depressive Disorder and MDMA-Assisted Psychotherapy for PTSD. Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He co-authored a paper on the influence of therapists’ first hand experience with psychedelics on psychedelic-assisted psychotherapy research and is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies. He maintains a private practice in New York City.
Casey Paleos, MD
Casey Paleos, MD is a psychiatrist and researcher with over a decade of experience in the use of psychedelic medicines for the treatment of mental illness, dating back to his work, while still in residency training, as a study therapist in the landmark Psilocybin Cancer Anxiety Study at NYU, where Dr. Guss was one of his mentors. Since then, Dr. Paleos was Co-Principal Investigator in the NYU-Bellevue Ketamine for Depression Study and has been treating patients in his private practice with both ketamine infusion therapy and ketamine-assisted psychotherapy since 2016. Presently, he is a study therapist and Principal Investigator, alongside Dr. Gorman, in the MAPS-sponsored MDMA-Assisted Psychotherapy for PTSD Phase 3 Clinical Trial, serves as Scientific Director at Mindbloom, Inc., and is a co-founder of Nautilus Sanctuary, a non-profit psychedelic research and clinical institution based in New York City.
Donna Sorgen, LMHC, LPC
Ketamine Certificate Program Director and Trainer
Donna Sorgen, LMHC,LPC (she/her) is a psychotherapist with over 25 years experience working with adults, children, adolescents, couples and groups. She is the Director/Owner of the Woodstock Therapy Center, a collective of practitioners providing a variety of services to the community including Ketamine Assistant Psychotherapy (KAP), psychiatric services , psychotherapy and holistic modalities. Donna has spent her career working with diverse clients in multiple settings. Her current private practice includes KAP, Psychotherapy and Psychedelic integration therapy. Donna has completed training in MDMA-Assisted Psychotherapy for PTSD through the Multidisciplinary Association for Psychedelic Studies(MAPS). She was a sushi chef, caterer and enjoys the outdoors and gardening.
Alexander Camargo, PsyD
Psychedelic Harm Reduction and Integration Certificate Program Director and Trainer
Dr. Camargo is a psychologist based in New York City and maintains a private practice in Manhattan. His work is heavily influenced by psychoanalytic and attachment theories. In addition, he provides psychedelic harm reduction and integration, helping clients prepare for psychedelic experiences, incorporate insights or cope with challenges post-experience. He also trained as a psilocybin therapist through Compass Pathways and serves as a therapist on an investigator-initiated clinical trial of psilocybin for Body Dysmorphic Disorder at New York Psychiatric Institute. Dr. Camargo’s clinical training focused on providing mental health services in low-fee clinics and hospitals to traditionally underserved communities in the Bronx, Brooklyn, and Nassau County.
Victor Cabral, MSW, LSW, CCTP-I
Director of Policy and Regulatory Affairs and Trainer
Victor Cabral, MSW, LSW, CCTP-I (He/Him/His) is a collaborative and strategic leader who has made an impact on human rights and historical inequalities throughout his career. Before joining Fluence, Victor served as Deputy Director for the Pennsylvania Governor’s Office of Advocacy and Reform where he helped lead the implementation of the Trauma-Informed PA Plan, establish the first Racial Day of Healing in Pennsylvania history, and developed free trauma trainings for Pennsylvanians in collaboration with internationally recognized experts.
He is a research-based systems thinker with expertise in policy development, advocacy, consulting, racial and communal trauma, and is a practicing psychotherapist with training in Internal Family Systems, Psychedelic-Assisted Psychotherapy (MDMA and Ketamine), and other modalities. Victor was also listed on the Students for Sensible Drug Policy’s list of ’40 Under 40 Outstanding BIPOC Leaders in Drug Policy in the United States’ for his work in psychedelic policy.
Jayne Gumpel, LCSW
Jayne is a licensed Clinical Social Worker with 30 years of clinical experience and training. Non ordinary states of consciousness often offer clients extraordinary learning opportunities for deep and sustainable change, and Jayne offers support and integration guidance for those who are attracted to healing modalities such as plant medicine, ketamine, body centered therapies and breathwork. She is a MBSR teacher, experienced meditator, and co-founder of Access Mindfulness, a non-profit dedicated to bringing mindfulness to schools. She offers clinical services remotely and in person Midtown East, NYC and Woodstock, New York.
Alan Davis, PhD
Dr. Alan Davis is an Assistant Professor of Social Work at Ohio State University and Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at Johns Hopkins University. Dr. Davis’s clinical experience includes working with people diagnosed with trauma-based psychological problems and includes providing evidenced-based treatments such as motivational interviewing, acceptance and commitment therapy, and psilocybin-assisted psychotherapy. His research interests focus on helping those suffering with substance use and mental health problems and developing ways to conceptualize substance use and mental health problems through a strengths-based approach. He recently completed a clinical trial of psilocybin therapy for depression and current trials exploring psychedelic treatment for patients with co-occurring alcohol use disorder and depression and patients with anorexia. He examines topics related to naturalistic psychedelic use among several populations including people of color who have experienced racial trauma, Spanish-speaking people, and people who use novel psychedelics such as 5-MeO-DMT.
Kelan Thomas, PharmD, MS, BCPS, BCPP
Kelan is an Associate Professor and Board Certified Psychiatric Pharmacist with outpatient behavioral health practice sites in San Francisco and Oakland. His research interests include adverse reactions and drug interactions related to psychiatric medications and psychedelic-assisted therapy.
Chantelle Thomas, PhD
Dr. Chantelle Thomas is a clinical psychologist and Executive Clinical Director of Windrose Recovery–a multi-level residential addiction treatment program offering detoxification, intensive outpatient programming and integrated ketamine assisted psychotherapy. Dr. Thomas has been directly involved clinical research trials at the University of Wisconsin School of Medicine and Public Health investigating the clinical use of psychedelics for over nine years. Current trials include the study of psilocybin for addiction and depression and MDMA for PTSD. She currently serves as a supervisor and trainer on the MAPS sponsored clinical trials of MDMA-Assisted Psychotherapy for PTSD for US and European clinical trials and Expanded Access Program. Dr. Thomas completed a postdoctoral fellowship in health psychology at the University of Wisconsin School of Medicine and Public Health and is a certified biofeedback practitioner. Her areas of specialization include chronic pain, trauma related disorders, substance use disorders, psychedelic integration.
Rebecca Kronman, LCSW
Rebecca is a licensed Clinical Social Worker and founder of Plant Parenthood, a digital and in-person community of parents who use psychedelics. At her private practice in Brooklyn, NY she works with creative professionals using mindfulness and experiential techniques to address depression, anxiety and life transitions. In addition, she works in the re-emerging clinical space of psychedelic harm reduction and integration, helping clients prepare for psychedelic experiences, incorporate insights or cope with challenges post-experience. Her experience includes Mindfulness-Based Stress Reduction, Mindfulness for Clinicians, Psychedelics 101 & 102, and Beyond Experience Psychedelic Integration Workshop.
Xiaojue Hu, MD
Dr. Xiaojue Hu is a psychiatrist based in New York City. She’s currently the Co-Investigator and a study therapist on a clinical trial investigating the impact of psilocybin on the treatment of major depression at the New York University School of Medicine. Xiaojue is also in private practice at an integrative mental health clinic, working with pioneering nutritional psychiatrist Drew Ramsey. She is trained in Focusing, a mind-body therapeutic approach, as well as psychedelic integration. Xiaojue is also interested in spirituality, women’s mental health, and cultural psychiatry, having worked as the leading psychiatrist at the Asian Bicultural Clinic at Gouverneur Health, an NYU-affiliated clinic providing care to the underserved. At Fluence, Xiaojue teaches psilocybin-assisted therapy for research therapists and is a Mentor for Certificate Program Trainees.
Johan Eriksson is a psychologist and therapist on his Sweden’s first clinical trial of psilocybin treatment for depression at Karolinska Institute in Stockholm, sponsored by Osmond Labs. He has a background in Cognitive Behavioral Therapy, Acceptance and Commitment Therapy (ACT), and Intensive Short-term Dynamic Psychotherapy (ISTDP). He works with clients for psychedelic preparation and integration, as well as general psychotherapy in private practice. In 2016 Johan co-founded the Swedish Network for Psychedelic Science (NPV), and in 2019 he arranged and participated in the first Psychedelics 101 and 102 in Sweden. Johan has also co-author a peer-reviewed paper on ACT and psychedelic-assisted psychotherapy. His web page is www.psykologiskintegration.se.
Shari Taylor, PhD
Dr. Shari Taylor is a somatic therapist practicing in New Orleans, LA. She employs methods drawn from humanistic, Jungian, transpersonal, and Eastern traditions. Using meditation, mindfulness exercises, yoga inspired movement, breathwork, and talk therapy, she helps her clients bridge the mind-body dichotomy. Her interests in yoga, meditation, and the transformative potential of expanded states of consciousness inform her style of practice. Dr. Taylor is currently working with the Multidisciplinary Association of Psychedelic Studies (MAPS), in the phase III study using MDMA-assisted psychotherapy for PTSD. Dr. Taylor holds a PhD in Psychology from Northcentral University, a Master’s of Science in Nursing from the University of South Alabama, and a Post-Master’s Certificate in Nursing from the University of Wisconsin-Madison specializing in the field of child/adolescent psychiatry.
Joseph McCowan, PsyD
Joseph McCowan, Psy.D, is a licensed clinical psychologist and psychotherapist, currently working in Los Angeles as a co-therapist in the MAPS sponsored Phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD. He is an alumni of MAPS’ MDMA Therapy Training for Communities of Color, held in August 2019. Additionally, Joseph works with the California Center for Psychedelic Therapy where he provides Ketamine Assisted Psychotherapy (KAP) and Psychedelic Integration Therapy. Joseph is deeply passionate about furthering education and awareness of the healing benefits of psychedelics for communities of color and in working to improve mental health outcomes for historically underserved communities. Joseph received his undergraduate degree in psychology from the University of California, Santa Barbara, and his doctorate in clinical psychology from the Chicago School of Professional Psychology.
Dan Roberts, MD, MSW
Dr. Dan Roberts is a psychiatrist and Clinical Instructor at the NYU Grossman School of Medicine. He is a study physician and session therapist on a number of trials involving MDMA and psilocybin at the NYU Langone Center for Psychedelic Medicine. Additionally, he completed advanced training for certification in ketamine-assisted psychotherapy through the Integrative Psychiatry Institute. Prior to a career transition into medicine and psychiatry, he worked as a clinical social worker, specializing in treating co-occurring disorders both in individual and group psychotherapy. Dan is also interested in meditation and contemplative practices, as well as depth psychology treatment approaches such as psychoanalysis and Jungian psychology.
Leah Gooch, Ed.M, 500RYT
Leah Gooch teaches yoga, meditation, writing, and art in order to help individuals approach a deeper awareness of their existence. After teaching art in New York City for eight years she facilitated the creation of a mural inside of Crossroads Detention Center in Brooklyn, completed by fifteen justice-involved youth. Leah is currently a teacher and Recreation Program Leader at a correctional facility. She facilitates public and private workshops and yoga lessons and is a reiki master practitioner. Her website is fourminutesaday.org – a reference to her initial commitment to meditate for (at least!) four minutes a day.
Kelly Sykes, PhD
Dr. Kelly Sykes is a child forensic psychologist and maintains a private practice in Brooklyn, New York. She works primarily with court referred families as a custody evaluator, parenting or family coordinator, or therapeutic supervisor. She also provides expert consultation and testimony in matters that concern parent-child contact problems, child sexual abuse evaluations, trauma & parenting, and adoption & termination of parental rights. Her work is heavily influenced by psychoanalysis and attachment theory. Kelly’s interest in psychedelic integration therapy evolved from years of working with court referred parents with histories of complex trauma, persistent mood disorders, and substance abuse problems. Noting that for some, talk therapies helped with insight but failed to inhibit endangering behavior or led to meaningful change such that they could parent their children. This sparked her interest in learning more about the role the brain plays in the chronicity of certain psychological conditions and the research on psychedelic treatments.
Dr. Lawrence Fischman
Lawrence Fischman, MD, is a psychiatrist and psychoanalyst, who has practiced in New York and Maine for 36 years. In addition to his full-time private practice in New York, he was a Clinical Instructor in Psychiatry at New York-Presbyterian/ Weill Cornell Medical Center. In 1996, he moved to Maine, and became a Clinical Instructor in Psychiatry at Tufts University School of Medicine Maine Track, where he also serves on the Admissions subcommittee. In 1983, he published a paper comparing psychedelic drug states with dreams and psychosis in Schizophrenia Bulletin. He retired from practice in 2021 to devote more time to reading and writing about psychoanalytic perspectives on psychedelic-assisted psychotherapy, including two papers which have appeared in Neuropsychoanalysis. He has enjoyed living, working and raising a family in Maine, and is excited by the emerging possibilities for integrating psychedelic experiences with psychoanalytically-based psychotherapy.
Brian Pilecki, PhD
Psilocybin-Assisted Therapy Certificate Program Advisor and Trainer
Dr. Brian Pilecki is a clinical psychologist at Portland Psychotherapy that specializes in the treatment of anxiety disorders, trauma and PTSD, and psychedelic-assisted therapy. He graduated from Fordham University completed a post-doctoral fellowship at The Warren Alpert Medical School of Brown University. Brian practices from an orientation based in Acceptance and Commitment Therapy (ACT) and has extensive experience in the areas of mindfulness and meditation that he incorporates into therapy with clients. He is an active researcher and has published on topics such as anxiety disorders, mindfulness, and psychedelics. At Portland Psychotherapy, Brian is a study therapist on a clinical trial investigating the use of MDMA-assisted therapy for the treatment of social anxiety disorder and understanding processes of change in how this novel form of treatment might work. He has given numerous workshops on topics related to psychedelics and is a consultant for the Oregon Health Authority in helping to design a program for psilocybin services in the state of Oregon. Brian is co-chairperson for the Psychedelic SIG in the Association for Contextual Behavioral Science and co-hosts a podcast called Altered States of Context about the intersection of psychedelics and psychotherapy.
Steph Barss, FNP, PMHNP
Psilocybin-Assisted Therapy Certificate Program Advisor
Steph Barss is a board-certified Family Nurse Practitioner and a Psychiatric Mental Health Nurse Practitioner. She has worked in Bend, Oregon for a nonprofit hospice and palliative care organization for nearly 20 years. She is passionate about supporting people along their journey, with a focus on working with those who have complex, life-limiting illness. As an advanced practice nurse, she works with people to explore what brings meaning and quality, to life and death. Steph is an outdoor enthusiast who brings nature into her healing practices. While not working, you can find her with family and friends hiking, running, skiing, climbing, or simply hanging in her hammock.
Lisa Wang, MD
Lisa Wang is a psychiatrist and psychotherapist based in New York and New Jersey. She takes an integrative approach to treatment that incorporates psychotherapy, psychopharmacology, and recommending other complementary treatment modalities as indicated. She is trained as a psilocybin therapist through Compass Pathways and has been a lead therapist on studies of psilocybin for treatment resistant depression and body dysmorphic disorder at New York State Psychiatric Institute. She is also a site physician for the MAPS-sponsored Phase 3 Clinical Trials of MDMA-Assisted Psychotherapy for PTSD. She has trained in a number of psychotherapy modalities including psychodynamic psychotherapy, cognitive behavioral therapy, dialectical behavior therapy, interpersonal psychotherapy, and psychedelic integration. She also aspires to bring her experience from the cushion as a meditator to all aspects of her work.
Sabina Sehgal, PhD
Sabina Sehgal, Ph.D. is a licensed clinical psychologist who has over a decade of experience as a specialist in cognitive behavioral therapy and health psychology. She completed her postdoctoral fellowship at Moores Cancer Center at the University of San Diego California (UCSD) and extensive training in empirically supported treatments at Rady Children’s Hospital, San Diego. Using self-regulatory interventions such as meditation and guided imagery, often integrated with behavioral medicine, Dr. Sehgal works with individuals, couples and families to support their transition through their diagnoses and promotes a positive supportive setting in which clients recover. Dr. Sehgal has been trained as a psilocybin therapist with Compass Pathways in an FDA approved program. Most recently, she joined the research team at UCSD and Kadima Neuropsychiatry Institute for a clinical trial using psilocybin for treating treatment resistant depression.
Candace Oglesby is a licensed professional counselor (LCPC) and board approved supervisor in the state of Maryland. She also holds a master’s degree in Clinical Psychology. She is the program director for the Ketamine Assisted Psychotherapy (KAP) program at Gladstone Psychiatry & Wellness, located in Columbia, MD. Candace specializes in working with diverse adult populations, specifically women of color, who present with substance use addiction and trauma like symptoms. Candace is certified in Eye Movement Desensitization Reprocessing (EMDR) and trained in Internal Family Systems (IFS). She is a consultant in training for EMDR. Candace also specializes in providing culturally competent/humility care for black and brown clients who have experienced racial trauma.
Candace is also the founder and owner of Jurnee Mental Health Consulting, LLC, a consulting business that provides support to individuals and businesses looking to deepen their understanding of mental health and provides support and resources to marginalized communities. Within her consulting business, she hosts healing circles for black women, which is a safe space for like-minded black women to come together to discuss issues around racial trauma and isolation. Candace is a DEI consultant, research clinical therapist, and featured presenter. The purpose of her work is to help bring awareness to diversity, equity, and inclusion.
In addition, Candace is a community ambassador for Black Therapist Rock (BTR) which is a non-profit organization that increases awareness of social and psychological issues impacting vulnerable communities and reducing stigma related to mental health. She is also a proud member of Delta Sigma Theta Sorority Incorporated. When Candace is not acting as psychotherapist, CEO, board member, and volunteer she is spending time with her partner, family, and friends.
Julia King Olivier, MD
Julia King Olivier, MD, is a Swiss trained psychiatrist and psychotherapist for adults, adolescents and children working for over a decade in a private practice in Geneva, Switzerland. She is part of the 2021 Boston Cohort of the CIIS Certificate Program in Psychedelic Therapy and Research and is currently completing part E of the five-part training in MDMA-assisted psychotherapy through the MAPS organization. She is the Founder of the Compassionate Care Center in Geneva, Switzerland, providing psychedelic assisted psychotherapy for the treatment of PTSD, depression and existential distress in patients with terminal illness. She is an avid Wim Hof breathwork practitioner and enjoys year round open water swimming with her husband and sons in Lake Geneva.
Leigh Ann de Monredon, NP
Leigh Ann de Monredon is a Nurse Practitioner who works in the field of substance use based in New Orleans, LA. Her practice comes from a non-biased belief in guiding individuals to optimal health through harm reduction, trauma informed care, motivational interviewing, and providing tools of empowerment that promote overall well being. She has been working within disenfranchised communities throughout her career advocating for equal access to resources by working with judges, numerous Boards, agencies and peer collaborations. She has been engaged in the psychedelic community and on-going learning to promote the powerful effect of guided non-ordinary states of consciousness as a potent modality of healing. Leigh Ann is currently working in a private Ketamine-Assisted Psychotherapy practice
Adi Flesher, M.Ed, LP
Adi Flesher, M.Ed, LP is a psychoanalyst in private practice in New York City. He is a long time educator and meditator with a passion for bringing contemplative practices into education. As the former director of the Contemplative Teaching and Learning Initiative at the Garrison Institute, he worked with thought leaders in the fields of neuroscience, psychology, and social and emotional learning, to help build the emerging field of Contemplative Teaching and Learning, which promotes awareness of self, other and the world by infusing experiential practices such as mindfulness, yoga, tai chi, art, music, reflective journaling and others into classroom life and subject teaching
He is a lecturer in the department of Counseling, Leadership, Literacy and Special Education at Lehman College, City University of New York, where he uses contemplative practices to help teachers honor and celebrate neurodiversity in their students and their self. He received an M.Ed in Mind, Brain and Education from the Harvard Graduate School of Education and a dual B.A. in Political Science/Jewish History from Columbia University and the Jewish Theological Seminary.
Aja Molinar, MA
Trainer and Special Projects Coordinator
Aja Molinar received her Master’s degree in Psychology from the New School for Social Research in NYC. Her interests centered around the intersection of boredom and depression. Before pursuing graduate studies, she worked as a Child Protection Specialist for the Kansas Department of Children and Families. Aja has assisted Dr. Elizabeth Nielson and Dr. Ingmar Gorman in writing a peer-reviewed article on psychedelic harm reduction and integration. At Fluence, she assists in the development of training materials, reviews diversity scholarship applications, and serves as a liaison for enterprise-level training programs. Aja also co-leads peer groups for ethics training. Outside of work, she is a photography enthusiast, mostly working toward improving her skills in portraiture.
Haya Al-Hejailan, MSc
Haya is a wellbeing coach, positive psychology practitioner and psychedelic integrationist. She holds a B.A. in psychology from Claremont McKenna College where she focused her senior thesis on the clinical uses of psychedelics. She recently received an MSc in applied positive psychology and coaching psychology from the University of East London, with a dissertation research project exploring the impact of psychedelic use on wellbeing in light of the COVID-19 pandemic. Haya is co-directing and co-producing The Psychedelic Renaissance Documentary and works as an events planner for The Psychedelic Society UK. She has previously worked as an administrator with Synthesis retreats and was involved with the French psychedelic society. Haya intends to dedicate her career in the field to help bridge the gap between psychedelic science and cultures in the SWANA/MENA region (South West Asia and North Africa/Middle East and North Africa).